Asunaprevir (BMS-650032) for the treatment of hepatitis C virus.
Expert review of anti-infective therapy • Vol. 13, Issue 11 • 2015
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection.
Therapeutics and clinical risk management • Vol. 10 • 2014
The discovery of asunaprevir (BMS-650032), an orally efficacious NS3 protease inhibitor for the treatment of hepatitis C virus infection.
Journal of medicinal chemistry • Vol. 57, Issue 5 • 2014
Highly efficient infectious cell culture of three hepatitis C virus genotype 2b strains and sensitivity to lead protease, nonstructural protein 5A, and polymerase inhibitors.
Hepatology (Baltimore, Md.) • Vol. 59, Issue 2 • 2014